Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more ...

Early-onset GI cancers diagnosed before age 50 are rising at alarming rates worldwide, underscoring the need for enhanced ...

Pfizer Inc ( (PFE) ), Astellas Pharma ( (ALPMF) ), Astellas Pharma ( (ALPMY)) announced an update on their ongoing clinical study.

Corona and flu infections may play a role in the recurrence of cancer in previously recovered patients. The viruses have been ...

A recent Aurora-based University of Colorado Cancer Center study found that COVID-19 infection in cancer patients can reawaken cancer cells and lead to metastasis. The study, published July 30 in ...

Overtreatment is considered harmful in terms of decreasing quality of life, wasting resources, and environmental damage.1–3 These risks are especially relevant when considering adjuvant chemotherapy ...

The global Cancer Pain Market is valued at USD 6983.5 Million in 2024 and is projected to reach a value of USD 12031.1 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 5.1% between 2025 and ...